Medicine
Metoclopramide 10 mg/2 mL injection
Metoclopramide 10 mg/2 mL injection is a generic prescription medicine for intramuscular, intravenous use, made by 11 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20 to 25°C (68 to 77°F). Protect from light by retaining in package…
Key facts
- Active ingredient (INN)
- Metoclopramide
- Brand
- Sold under the generic name
- Strength
- 10 mg/2 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous
- Packs
- 25 vials of 2 mL, 24 blister pack of 2 mL, 10 vials of 2 mL and 18 more
- Manufacturers
- Avet PharmaceuticalsIndiaHealthFirstCardinal HealthMedical Purchasing SolutionsFresenius KabiHospiraTeva Parenteral MedicinesAvenacyBaxter HealthcareHenry Schein
- Origin register
- US FDA, United States
- Storage
- Store at 20 to 25°C (68 to 77°F). Protect from light by retaining in package until time of use. Do not store open single-use vials for later use, as they contain no preservative.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A03FA01 Metoclopramide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 December 1991
- Identifiers
- RxCUI 311670, 727619DailyMed set ID 7678bcd5-1071-0a9b-e053-2a91aa0a3853, 55b3fecb-f60c-474b-9530-915b0e68bf85, cc739885-e10e-4bcb-a781-c726c518f3d1 +16NDC 51662-1288, 55154-7832, 76045-213 +16Application ANDA073118, ANDA091392, ANDA073135 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 2 mL in 1 vial | 23155-240-41 | Avet PharmaceuticalsIndia | 3 January 2014 |
| 24 blister pack in 1 carton / 1 syringe, glass in 1 blister pack / 2 mL in 1 syringe, glass | 76045-101-20 | Fresenius Kabi | 3 May 2013 |
| 24 blister pack in 1 carton / 1 syringe, glass in 1 blister pack / 2 mL in 1 syringe, glass | 76045-213-20 | Fresenius Kabi | 28 February 2022 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 0409-3414-11 | Hospira | 26 August 2024 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 0409-5255-15 | Hospira | 26 August 2024 |
| 25 vial, single-use in 1 tray / 2 mL in 1 vial, single-use | 0703-4502-04 | Teva Parenteral Medicines | 1 December 1991 |
| 10 vial, single-use in 1 carton / 2 mL in 1 vial, single-use | 0703-4502-93 | Teva Parenteral Medicines | 4 September 2024 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 36000-366-25 | Baxter Healthcare | 11 September 2026 |
| 5 vial, single-use in 1 bag / 2 mL in 1 vial, single-use | 55154-0450-5 | Cardinal Health | 10 December 1993 |
| 5 vial in 1 bag / 2 mL in 1 vial | 55154-2353-5 | Cardinal Health | 22 September 2009 |
| 5 vial, single-dose in 1 bag / 2 mL in 1 vial, single-dose | 55154-7832-5 | Cardinal Health | 9 July 2025 |
| 2 mL in 1 vial, single-dose | 51662-1288-1 | HealthFirst | 22 September 2018 |
| 25 pouch in 1 case / 1 vial, single-use in 1 pouch / 2 mL in 1 vial, single-use | 51662-1288-3 | HealthFirst | 1 October 2022 |
| 1 syringe, glass in 1 blister pack / 2 mL in 1 syringe, glass | 51662-1367-1 | HealthFirst | 14 October 2019 |
| 25 pouch in 1 case / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 51662-1670-3 | HealthFirst | 2 February 2006 |
| 1 vial, single-use in 1 bag / 2 mL in 1 vial, single-use | 71872-7076-1 | Medical Purchasing Solutions | 29 May 2018 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7265-1 | Medical Purchasing Solutions | 24 August 2021 |
| 1 vial, single-dose in 1 bag / 2 mL in 1 vial, single-dose | 71872-7346-1 | Medical Purchasing Solutions | 10 April 2025 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 83634-779-02 | Avenacy | 30 June 2024 |
| 1 vial in 1 bag / 2 mL in 1 vial | 0404-9771-02 | Henry Schein | 30 April 2026 |
| 2 mL in 1 vial, single-dose | 84549-414-11 | ProPharma Distribution | 18 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 February 1979 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Metoclopramide
Clinical summary
Metoclopramide is a dopamine-2 receptor antagonist indicated for the treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy, among other approved uses. MedsAcross supplies Metoclopramide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MetoclopramideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Metoclopramide prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Metoclopramide 10 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.